Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: A prospective pilot study

Cancer Chemotherapy and Pharmacology

Volumn 68, Issue 1, 2011, Pages 267-274

  Muñoz Casares, Francisco C ^a   Rufián, Sebastián ^a   Arjona Sánchez, Álvaro ^a   Rubio, María J ^a   Díaz, Rafael ^a   Casado, Ángela ^a   Naranjo, Álvaro ^a   Díaz Iglesias, Carlos J ^a   Ortega, Rosa ^a   Muñoz Villanueva, María C ^a   Muntané, Jordi ^a   Aranda, Enrique ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Intraperitoneal chemotherapy; Morbidity; Neoadjuvant; Ovarian cancer; Paclitaxel; Peritonectomy

Indexed keywords

ANALGESIC AGENT; CA 125 ANTIGEN; CARBOPLATIN; PACLITAXEL;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ABDOMINAL SURGERY; ABSENCE OF SIDE EFFECTS; ADULT; AGED; ALOPECIA; ANGIONEUROTIC EDEMA; ANOREXIA; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; ASCITES; ASTHENIA; BLOOD TOXICITY; BRAIN DISEASE; CANCER ADJUVANT THERAPY; CANCER STAGING; CARCINOMATOUS PERITONITIS; CELLULITIS; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; CONVULSION; CYTOREDUCTIVE SURGERY; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG SAFETY; DYSPNEA; FEMALE; HUMAN; HUMAN TISSUE; LAPAROSCOPY; MICTURITION DISORDER; MONOTHERAPY; MOTOR NEUROPATHY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA; OVARY CANCER; OVERALL SURVIVAL; PARESTHESIA; PERITONECTOMY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADICAL RESECTION; SEROMA;

EID: 85027949629     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-011-1646-4     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-249
2. Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29-42
3. Sugarbaker PH (2009) Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer. Curr Opin Obstet Gynecol 21:15-24
4. Bijelic L, Jonson A, Sugarbaker PH (2007) Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol 18:1943-1950 (Pubitemid 350286229)
5. Elias D, Delperro JR, Sideris L, Benhamou E, Pocard M, Baton O, Giovannini M, Lasser P (2004) Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Ann Surg Oncol 11:518-521 (Pubitemid 40486734)
6. Alberts DS, Liu PY, Hannigan EV, O'Toole R, Williams SD, Young JA, Franklin EW, Clarke-Pearson DL, Malviya VK, DuBeshter B (1996) Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med 335:1950-1955
7. Markman M, Bundy BN, Alberts DS, Fowler JM, Clark-Pearson DL, Carson LF, Wadler S, Sickel J (2001) Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the gynecologic oncology group, Southwestern oncology group, and Eastern cooperative oncology group. J Clin Oncol 19:1001-1007
8. Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL, Burger RA, Group Gynecologic Oncology (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34-43 (Pubitemid 43048949)
9. Tentes AA, Tripsiannis G, Markakidis SK, Karanikiotis CN, Tzegas G, Georgiadis G, Avgidou K (2003) Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer. Eur J Surg Oncol 29:69-73 (Pubitemid 36181781)
10. Muñoz-Casares FC, Rufián S, Rubio MJ, Lizárraga E, Díaz- Iglesias C, Aranda E, Ciria R, Muntané J, Barrios P, Torres-Melero J, González-Moreno S, González-Bayón L, Camps B, Bretcha P, Farré J, Ortega-Pérez G, Gómez-Portilla A (2007) Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals. Clin Transl Oncol 9:652-662
11. Rufián S, Muñoz-Casares FC, Briceño J, Díaz CJ, Rubio MJ, Ortega R, Ciria R, Morillo M, Aranda E, Muntané J, Pera C (2006) Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent o primary ovarian cancer. J Surg Oncol 94:316-324 (Pubitemid 44330855)
12. NationalCancer Institute (2006).Cancer therapy evaluation program, common terminology criteria for adverse events v3.0 (CTCAE). Available: http://ctep.cancer.gov/protocoldevelopment/electronic- applications/docs/ ctcaev3.pdf. Published August 9, 2006
13. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a metaanalysis. J Clin Oncol 20:1248-1259 (Pubitemid 34177431)
14. Ryu KS, Kim JH, Ko HS, Kim JW, Ahn WS, Park YG, Kim SG, Lee JM (2004) Effects of intraperitoneal hyperthermic chemotherapybin ovarian cancer. Gynecol Oncol 94:325-332 (Pubitemid 39024534)
15. Muñoz-Casares FC, Rufián S, Rubio MJ, Díaz CJ, Díaz R, Casado A, Arjona A, Muñoz-Villanueva MC, Muntané J (2009) The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer. Clin Transl Oncol 11:753-759
16. Weinberg LE, Rodriguez G, Hurteau JA (2010) The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer. J Surg Oncol 101:334-343
17. Francis P, Rowinsky E, Schneider J, Hakes T, Hoskins W, Markman M (1995) Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a gynecologic oncology group pilot study. J Clin Oncol 13:2961-2967
18. de Bree E, Rosing H, Michalakis J, Romanos J, Relakis K, Theodoropoulos TA, Beijnen JH, Georgoulias V, Tsiftsis DD (2006) Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination. Eur J Surg Oncol 32:666-670 (Pubitemid 44087882)
19. De Iaco P, Musto A, Orazi L, Zamagni C, Rosati M, Allegri V, Cacciari M, Al-Nahhas A, Rubello D, Venturoli S, Fanti S (2010) FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy. Eur J Radiol [Epud ahead of print]
20. Yonemura Y, Bandou E, Sawa T, Yoshimitsu Y, Endou Y, Sasaki T, Sugarbaker PH (2006) Neoadjuvant treatment of gastric cancer with peritoneal dissemination. Eur J Surg Oncol 32:661-665 (Pubitemid 44063995)